JFS Wealth Advisors’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-226
| Closed | -$22K | – | 565 |
|
|
2019
Q3 | $22K | Hold |
226
| – | – | 0.01% | 294 |
|
|
2019
Q2 | $21K | Hold |
226
| – | – | 0.01% | 303 |
|
|
2019
Q1 | $21K | Buy |
226
+130
| +135% | +$11.4K | 0.01% | 296 |
|
|
2018
Q4 | $6K | Hold |
96
| – | – | ﹤0.01% | 386 |
|
|
2018
Q3 | $9K | Hold |
96
| – | – | ﹤0.01% | 424 |
|
|
2018
Q2 | $8K | Sell |
96
-19
| -17% | -$1.58K | ﹤0.01% | 388 |
|
|
2018
Q1 | $10K | Buy |
115
+95
| +475% | +$9.12K | ﹤0.01% | 371 |
|
|
2017
Q4 | $2K | Buy |
20
+19
| +1,900% | +$2.14K | ﹤0.01% | 497 |
|
|
2017
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 470 |
|
|
2017
Q2 | $0 | Buy |
+1
| New | +$123 | ﹤0.01% | 480 |
|
|
2016
Q2 | – | Sell |
-24
| Closed | -$2K | – | 670 |
|
|
2016
Q1 | $2K | Buy |
+24
| New | +$2.47K | ﹤0.01% | 545 |
|
|
2015
Q3 | – | Sell |
-44
| Closed | -$5K | – | 618 |
|
|
2015
Q2 | $5K | Sell |
44
-8
| -15% | -$915 | ﹤0.01% | 415 |
|
|
2015
Q1 | $6K | Sell |
52
-68
| -57% | -$8.13K | ﹤0.01% | 410 |
|
|
2014
Q4 | $13K | Buy |
120
+67
| +126% | +$7.07K | ﹤0.01% | 350 |
|
|
2014
Q3 | $5K | Sell |
53
-7
| -12% | -$632 | ﹤0.01% | 388 |
|
|
2014
Q2 | $5K | Buy |
+60
| New | +$4.56K | ﹤0.01% | 385 |
|
Other funds holding CELG
JFS Wealth Advisors's CELG Position: Q4 2019 in Review
JFS Wealth Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 226 shares — an estimated $22K sold.
JFS Wealth Advisors first reported a position in CELG in Q2 2014 and held it in 16 quarters. The position peaked at $22K in Q3 2019. 3 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- JFS Wealth Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- JFS Wealth Advisors sold 226 Celgene Corp shares in Q4 2019, an estimated $22K.
- JFS Wealth Advisors first reported a position in Celgene Corp in Q2 2014 and held it in 16 quarters.
- JFS Wealth Advisors's Celgene Corp position peaked at $22K in Q3 2019.
- 3 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on JFS Wealth Advisors's 13F filing for Q4 2019, filed 3 Feb 2020.